You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Fredric N. Eshelman

Executive Chairman at The Medicines Co.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Fredric N. Eshelman's strongest connections.

People Most Closely Connected to Fredric N. Eshelman

Click the names below to expand relationship details.
William R. Moore, Jr.
Former President, Chief Executive Officer & Director at Innocrin Pharmaceuticals, Inc.
S. Edward Torres
Co-Founder & Managing Director at Lilly Ventures Management Co.
Douglas Reed
General Partner at Hatteras Venture Partners
Clive A. Meanwell
Chief Executive Officer & Director at The Medicines Co.
Kristopher A. Wood
CIO at Lurie Investments
Robert J. Schotzinger
President & Chief Executive Officer & Director at Viamet Pharmaceuticals Corp.
Richard S. Kent
President at Maverick Label
Andrew C. von Eschenbach
Vice President Revenue Cycle at Trinity Mother Frances Health System
Sailash I. Patel
Chief Executive Officer & Director at Meryx, Inc.
Sean Ianchulev
Chief Medical Officer & Vice President-Medical Affairs at Transcend Medical, Inc.
Stuart O. Bondurant
Former Dean of the School of Medicine at The University of North Carolina at Chapel Hill
Ernest Mario
Venture Partner at Pappas Capital
Charles F. Osborne, Jr.
Chief Financial Officer & Secretary at Innocrin Pharmaceuticals, Inc.
Ebrahim Versi
Co-Founder at Dignify Therapeutics
Daniel J. Ricca
Co-Founder at Dignify Therapeutics
Chad Roy
Chief Executive Officer & Director at Asepticys
Steven D. Weinstein
Managing Director at Novartis Venture Fund
Elizabeth H. S. Wyatt
Former Consultant & Academic Administrator at Harvard University - Harvard Business School
2,031 more connections are available with a RelSci Professional subscription.